Genomic Mapping Study Finds Largest Set of Genes Related to Major Risk Factor for Heart Disease

Aug 9th of 2010

Research Heart Attack Genetics FEATURED

Scanning the genomes of more than 100,000 people from all over the world, scientists report the largest set of genes discovered underlying high cholesterol and high triglycerides -- the major risk factors for coronary heart disease, the nation's number one killer. Taken together, the gene variants explain between a quarter and a third of the inherited portions of cholesterol and triglyceride measured in the blood. The research, representing scientists from 17 countries, appears in two papers ...

Coronary Calcium Score to Traditional Risk Factors Improves Risk Assessment for Heart Disease

Apr 27th of 2010

Diseases Cardiovascular Heart Attack

Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

FDA Approves New Indication for Crestor (Rosuvastatin)

Feb 9th of 2010

Drugs Heart Attack Stroke

On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new indication is for reducing the likelihood of a heart attack or stroke or the need for a procedure to treat blocked or narrowed arteries in patients who have never been told they have heart disease but are nevertheless at increased risk of a cardiac event.

Researchers Develop Innovative Imaging System to Study Sudden Cardiac Arrest

Oct 31st of 2009

Research Cardiovascular Heart Attack

A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest. Tested in animal models, the system could dramatically advance scientists' understanding of the relationship between metabolic disorders and heart rhythm disturbances in humans that can lead to cardiac arrest and death, and provide a platform fo...

FDA Approves Effient to Reduce the Risk of Heart Attack in Angioplasty Patients

Jul 13th of 2009

Diseases Heart Attack

The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.

ADVERTISEMENT      |      ADVERTISE WITH US